Evogene Reports Second Quarter 2023 Financial Results
18 August 2023, Israel: Evogene Ltd. (Nasdaq: EVGN, TASE: EVGN), a leading computational biology company aiming to revolutionize life-science-based product discovery and
Read More
Evogene
Biomica Opens Second Site to Advance Its Immuno-Oncology Drug Trials at Davidoff Center
15 August 2023, Israel: Biomica Ltd., a clinical-stage biopharmaceutical company developing innovative microbiome-based therapeutics and a subsidiary of Evogene Ltd. (Nasdaq: EVGN, TASE:
Read More
Evogene Schedules Second Quarter 2023 Financial Results Release & Conference Call for August 17, 2023
01 August 2023, Rehovot: Evogene Ltd. (Nasdaq: EVGN, TASE: EVGN), a leading computational biology company targeting to revolutionize life-science product discovery and
Read More
Evogene’s ChemPass AI Tech-Engine is Introduced with New Breakthrough Machine Learning Technology for Target-Protein Discovery
26 July 2023, Rehovot: Evogene Ltd. (Nasdaq: EVGN, TASE: EVGN), a leading computational biology company targeting to revolutionize life-science product discovery
Read More
Lavie Bio Announces Licensing Agreement for Bio-Fungicides with Corteva Agriscience
17 July 2023, Israel: Lavie Bio Ltd., a subsidiary of Evogene Ltd. (Nasdaq: EVGN, TASE: EVGN), and a leading ag-biologicals company that
Read More
Casterra Announces Additional $2.2 Million of Purchase Orders to Supply Castor Seeds for New African Territories
03 July 2023, Israel: Casterra Ag Ltd. (“Casterra”), an integrated castor cultivation solution company and a subsidiary of Evogene Ltd. (“Evogene”)
Read More
Casterra Signs a Framework Agreement with a World Leading Oil and Gas Company to Sell Its Castor Seeds for Sustainable Biofuel Production, with Initial Purchase Orders of $9.1 Million
22 June 2023, Israel: Casterra Ag Ltd. (“Casterra”), an integrated castor cultivation solution company and a subsidiary of Evogene Ltd. (“Evogene”)
Read More
Lavie Bio Receives Canadian Regulatory Approval for ThrivusTM, Expanding Global Reach
24 May 2023, Israel: Lavie Bio Ltd., a subsidiary of Evogene Ltd. (Nasdaq: EVGN, TASE: EVGN), and a leading ag-biological company focusing on
Read More
Evogene Reports First Quarter 2023 Financial Results
19 May 2023, Israel: Evogene Ltd. (Nasdaq: EVGN, TASE: EVGN), a leading computational biology company aiming to revolutionize life-science-based product discovery and development utilizing
Read More
Evogene Ag-Seed Division Awarded Prestigious €1.2M Horizon Grant to Develop Oil-Seed Crops with High CO2 Assimilation & Drought Tolerance
10 May 2023, Israel: The Ag-Seed Division of Evogene Ltd. (Nasdaq: EVGN, TASE: EVGN)(“Evogene”), a leading computational biology company targeting to revolutionize
Read More